AccScience Publishing / ITPS / Volume 7 / Issue 2 / DOI: 10.36922/itps.1418
Cite this article
Journal Browser
Volume | Year
News and Announcements
View All

Sujok as an alternative therapy to reduce dyspnea in patients with respiratory problems

Intansari Nurjannah1* Zakiah Novianti1 Agus Suharto1 Muhammad Yasir Sudarmo1 Ki Hariyadi1
Show Less
1 Department of Mental Health and Community Nursing, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
INNOSC Theranostics and Pharmacological Sciences 2024, 7(2), 1418
Submitted: 30 July 2023 | Accepted: 30 November 2023 | Published: 28 February 2024
© 2024 by the Authors). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( )

The management of dyspnea has received little attention as compared to other potentially severe symptoms of the disease, such as acute and chronic pain. The previous case reports indicated that Sujok therapy can alleviate dyspnea in a short time. This study aimed to determine whether Sujok therapy could reduce dyspnea symptoms in patients with oxygen saturation of less than 96%. Sujok originated from the Korean language, which consisted of the words Su and Jok, denoting hand and foot, respectively. Sujok therapy involves manipulating the hands or feet through massaging, coloring, or attaching seeds, magnets, or needles. This quasi-experimental study involved 34 males and 26 females with oxygen saturation of < 96% and experienced dyspnea with a grade of more than 2 on the Likert scale (1 – 5). Respondents were divided into an intervention group (IG) (n = 30) and a control group (CG) (n = 30), where IG was given the Sujok therapy. Measurements were taken for both groups at 0, 5, 15, and 30 min. The study reported mean ages of 55.6 ± 13.49 and 60.63 ± 9.26 in CG and IG, respectively. The increase in oxygen saturation was statistically significant in the overall measurement time in IG (P < 0.01). After 30 min, the average grade of dyspnea was 3 (moderate) for CG and 2 (mild) for IG. In CG, dyspnea decreased significantly at 30 min by 0.185 (P = 0.001; P < 0.05), whereas in IG, dyspnea decreased significantly at 5 min by 0.649 (P < 0.01). In conclusion, Sujok therapy can increase oxygen saturation and reduce the dyspnea grade in patients with respiratory problems.

Sujok therapy
Respiratory problem
Universitas Gadjah Mada
  1. Parshall MB, Schwartzstein RM, Adams L, et al. An official American thoracic society statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435-452. doi: 10.1164/rccm.201111-2042ST


  1. Pisani L, Hill NS, Pacilli AM, Polastri M, Nava S. Management of dyspnea in the terminally ill. Chest. 2018;154:925-934. doi: 10.1016/j.chest.2018.04.003


  1. Budhwar N, Syed Z. Chronic dyspnea: Diagnosis and evaluation. Am Fam Physician. 2020;101:542-548.


  1. Pratter MR, Curley FJ, Dubois J, Irwin RS. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med. 1989;149:2277-2282. doi: 10.1001/archinte.1989.00390100089021


  1. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002;162:1477-1481. doi:10.1001/archinte.162.13.1477


  1. Depiazzi J, Everard ML. Dysfunctional breathing and reaching one’s physiological limit as causes of exercise-induced dyspnoea. Breathe (Sheff). 2016;12:120-129. doi: 10.1183/20734735.007216


  1. Choi HS, Han SS, Choi HA. Dyspnea and palpitation during pregnancy. Korean J Intern Med. 2001;16:247-249. doi: 10.3904/kjim.2001.16.4.247


  1. Ha D, Ries AL. Characterization of dyspnea in veteran lung cancer survivors following curative-intent therapy. J Cardiopulm Rehabil Prev. 2020;40:120. doi: 10.1097/HCR.0000000000000464


  1. Mendoza TR, Kehl KL, Bamidele O, et al. Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: An observational study. Support Care Cancer. 2019;27:3439-3447.


  1. Viniol A, Beidatsch D, Frese T, et al. Studies of the symptom dyspnoea: A systematic review. BMC Fam Pract. 2015;16:152.


  1. Mahler DA. Evaluation of dyspnea in the elderly. Clin Geriatr Med. 2017;33:503-521.


  1. Ho S, O’Mahony MS, Steward JA, Breay P, Buchalter M, Burr ML. Dyspnoea and quality of life in older people at home. Age Ageing. 2001;30:155-159. doi: 10.1016/S0749-0690(02)00050-2


  1. Morélot-Panzini C, Adler D, Aguilaniu B, et al. Breathlessness despite optimal pathophysiological treatment: On the relevance of being chronic. Eur Respir J. 2017;50:1701159. doi: 10.1183/13993003.01159-2017


  1. Campbell ML, Yarandi H, Dove-Medows E. Oxygen is nonbeneficial for most patients who are near death. J Pain Symptom Manage. 2013;45:517-523. doi: 10.1016/j.jpainsymman.2012.02.012


  1. Delgado-Guay MO, Parsons HA, Li Z, Palmer LJ, Bruera, E. Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer. 2009;115:437-445. doi: 10.1002/cncr.24017


  1. Nurjannah I. Fourteen days struggling to deal with COVID- 19 using Su Jok therapy: A case report. J Community Empowerment Health. 2022;5:71-76. doi: 10.22146/jcoemph.66453


  1. Haven B, Sharma S. Oxygen saturation. In: StatPearls. Treasure Island FL. StatPearls Publishing; 2018.


  1. Hinkelbein J, Koehler H, Genzwuerker HV, Fiedler F. Artificial acrylic finger nails may alter pulse oximetry measurement. Resuscitation. 2007;74:75-82.


  1. Pesola GR, Ahsan H. Dyspnea as an independent predictor of mortality. Clin Respir J. 2016;10:142-152. doi: 10.1111/crj.12191


  1. Lee WW, Mayberry K, Crapo R, Jensen RL. The accuracy of pulse oximetry in the emergency department. Am J Emerg Med. 2000;18:427-431. doi: 10.1053/ajem.2000.7330


  1. Luks AM, Swenson ER. Pulse oximetry for monitoring patients with COVID-19 at home. Potential pitfalls and practical guidance. Ann Am Thrac Soc. 2020;17:1040-1046. doi: 10.1513/AnnalsATS.202005-418FR


  1. American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211- 217.


  1. Torp KD, Modi P, Simon LV. In: StatPearls. United States: StatPearls Publishing; 2021.


  1. Sütçü Çiçek H, Gümüs S, Deniz Ö, et al. Effect of nail polish and henna on oxygen saturation determined by pulse oximetry in healthy young adult females. Emerg Med J. 2011;28:783-785. doi:10.1136/emj.2010.096073


  1. Bickler PE, Feiner JR, Severinghaus JW. Effects of skin pigmentation on pulse oximeter accuracy at low saturation. Anesthesiology. 2005;102:715-719. doi: 10.1097/00000542-200504000-00004


  1. Feiner JR, Severinghaus JW, Bickler PE. Dark skin decreases the accuracy of pulse oximeters at low oxygen saturation: The effects of oximeter probe type and gender. Anesth Analg. 2007;105:S518-S523. doi: 10.1213/01.ane.0000285988.35174.d9


  1. Kako J, Morita T, Yamaguchi T, et al. Evaluation of the appropriate washout period following fan therapy for dyspnea in patients with advanced cancer: A pilot study. Am J Hosp Palliat Care. 2018;35:293-296. doi: 10.1177/1049909117707905


  1. Kako J, Morita T, Yamaguchi T, et al. Fan therapy is effective in relieving dyspnea in patients with terminally ill cancer: A parallel-arm, randomized controlled trial. J Pain Symptom Manage. 2018;56:493-500. doi: 10.1016/j.jpainsymman.2018.07.001


  1. Qian Y, Wu Y, Rozman de Moraes A, et al. Fan therapy for the treatment of dyspnea in adults: A systematic review. J Pain Symptom Manage. 2019;58:481-486. doi: 10.1016/j.jpainsymman.2019.04.011


  1. László A, Albrecht S, Hager S, et al. Treatment of therapy resistant dyspnea with traditional Chinese medicine. Com Alt Med. 2018;2018:1-6. doi: 10.9016/CAM-105/10000105


  1. Ergin E, Midilli TS, Baysal E. The effect of music on dyspnea severity, anxiety, and hemodynamic parameters in patients with dyspnea. J Hosp Palliat Nurs. 2018;20:81-87. doi: 10.1097/NJH.0000000000000403


  1. Horowitz RI, Freeman PR, Bruzzese J. Efficacy of glutathione therapy in relieving dyspnea associated with COVID- 19 pneumonia: A report of 2 cases. Respir Med Case Rep. 2020;30:101063. doi: 10.1016/j.rmcr.2020.101063


  1. Özer Z, Turan GB, Aksoy M. The effects of yoga on dyspnea, sleep and fatigue in chronic respiratory diseases. Complement Ther Clin Pract. 2021;43:101306. doi: 10.1016/j.ctcp.2021.101306


  1. Hayen A, Herigstad M, Pattinson KT. Understanding dyspnea as a complex individual experience. Maturitas. 2013;76:45-50. doi: 10.1016/j.maturitas.2013.06.005


  1. Gendron LM, Nyberg A, Saey D, Maltais F, Lacasse Y. Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;10:CD012290. doi: 10.1002/14651858.CD012290.pub2


  1. Coyle ME, Shergis JL, Huang ET. Acupuncture therapies for chronic obstructive pulmonary disease: A systematic review of randomized, controlled trials. Altern Ther Health Med. 2014;20:10-23.


  1. Park JW. Sujok for Everybody. Jaipur, RJ: Su Jok Therapy Centre; n.d.


  1. Nurjannah I, Hariyadi K. Su jok as a complementary therapy for reducing level of pain: A retrospective study. Complement Ther Clin Pract. 2021;43:101337. doi: 10.1016/j.ctcp.2021.101337


  1. Nurjannah I. “Su Jok” therapy and serology profile monitoring for managing chest pain at home while avoiding hospital admission during the COVID-19 pandemic: A case study. Belitung Nurs J. 2020;6:229-232. doi: 10.33546/bnj.1243


  1. Nurjannah I. Su Jok therapy for managing chest pain during COVID-19 pandemic period: A case report. BIO Web Conf. 2021;41:03004. doi: 10.1051/bioconf/20214103004


  1. Nurjannah I, Novianti Z, Suharto A, Sudarmo MY, Hariyadi K. Su Jok therapy by twist and seed method of therapy to reduce the level of fear on COVID-19’s patient: A case series. Int J R Med Sci. 2021;9:3148-3155. doi: 10.18203/2320-6012.ijrms20213947


  1. Nurjannah I, Zakiah N, Agus S, Yasir MS, Ki H. In Sujok World: An official Newsletter of ISA. Vol. 2. Nagpur: International Sujok Association; 2022. p. 8-13.


  1. Shamsuddin KA. Colour Therapy. ???: Burkhiya Education Foundation (Regd); 2007.


  1. Park JW. The Six Energy Theory Illustrated Handbook. Jaipur: Smile Academy Pvt Ltd.; 2002.


  1. Nurjannah I, Isa SA. Aplikasi Sistem Pengobatan Berdasarkan Teori Triorigin (Buku ke-1: Triorigin Sequence). Sanford: Mocomedia; 2021.


  1. Nurjannah I. Terapi Su Jok Untuk Masalah Kesehatan Sederhana. Sanford: Mocomedia; 2020.


  1. Park JW. Su Jok Seed Therapy. India: Su Jok Therapy Centre (India) Pvt Ltd.; 2000.


  1. International Sujok Association. How to Stimulate? 2012. Availble from: [Last accessed on 2023 Jul 27].
Conflict of interest
The authors declare no competing interests in this study.
Back to top
INNOSC Theranostics and Pharmacological Sciences, Electronic ISSN: 2705-0823 Published by AccScience Publishing